New Results
Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells
Deli Huang, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mariia V. Guryleva, Mary Tenuta, Roberta P. Fuller, Torben Schiffner, Justin R. Abadejos, Lauren Couvrette, Tanya R. Blane, Karen Saye, Wenjuan Li, Elise Landais, Alicia Gonzalez-Martin, William Schief, Ben Murrell, Dennis R. Burton, David Nemazee, James E. Voss
doi: https://doi.org/10.1101/2020.03.17.989699
Deli Huang
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Jenny Tuyet Tran
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Alex Olson
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Thomas Vollbrecht
2Department of Medicine, The University of California San Diego, La Jolla CA, USA
Mariia V. Guryleva
3Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
4Faculty of Bioengineering and Bioinformatics, Moscow Lomonosov State University, Moscow Russia
Mary Tenuta
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Roberta P. Fuller
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
5Scripps Consortium for HIV/AIDS Vaccine Immunogen Development (CHAVD), The Scripps Research Institute, La Jolla CA, USA
6International AIDS Vaccine Initiative Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla CA USA
Torben Schiffner
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
5Scripps Consortium for HIV/AIDS Vaccine Immunogen Development (CHAVD), The Scripps Research Institute, La Jolla CA, USA
6International AIDS Vaccine Initiative Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla CA USA
Justin R. Abadejos
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Lauren Couvrette
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
7Faculty of Science, University of Ottawa, Ottawa, Canada
Tanya R. Blane
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Karen Saye
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
5Scripps Consortium for HIV/AIDS Vaccine Immunogen Development (CHAVD), The Scripps Research Institute, La Jolla CA, USA
6International AIDS Vaccine Initiative Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla CA USA
Wenjuan Li
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Elise Landais
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
5Scripps Consortium for HIV/AIDS Vaccine Immunogen Development (CHAVD), The Scripps Research Institute, La Jolla CA, USA
Alicia Gonzalez-Martin
8Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain
William Schief
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
5Scripps Consortium for HIV/AIDS Vaccine Immunogen Development (CHAVD), The Scripps Research Institute, La Jolla CA, USA
6International AIDS Vaccine Initiative Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, United States
Ben Murrell
3Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Dennis R. Burton
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
5Scripps Consortium for HIV/AIDS Vaccine Immunogen Development (CHAVD), The Scripps Research Institute, La Jolla CA, USA
6International AIDS Vaccine Initiative Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla CA USA
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, United States
David Nemazee
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
James E. Voss
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla CA, USA
Article usage
Posted March 17, 2020.
Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells
Deli Huang, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mariia V. Guryleva, Mary Tenuta, Roberta P. Fuller, Torben Schiffner, Justin R. Abadejos, Lauren Couvrette, Tanya R. Blane, Karen Saye, Wenjuan Li, Elise Landais, Alicia Gonzalez-Martin, William Schief, Ben Murrell, Dennis R. Burton, David Nemazee, James E. Voss
bioRxiv 2020.03.17.989699; doi: https://doi.org/10.1101/2020.03.17.989699
Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells
Deli Huang, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mariia V. Guryleva, Mary Tenuta, Roberta P. Fuller, Torben Schiffner, Justin R. Abadejos, Lauren Couvrette, Tanya R. Blane, Karen Saye, Wenjuan Li, Elise Landais, Alicia Gonzalez-Martin, William Schief, Ben Murrell, Dennis R. Burton, David Nemazee, James E. Voss
bioRxiv 2020.03.17.989699; doi: https://doi.org/10.1101/2020.03.17.989699
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)